Orforglipron es un agonista GLP-1 oral de molcula pequea en desarrollo que ha demostrado reducciones de peso del 9,6% con la dosis de 36 mg en pacientes con obesidad y diabetes tipo 2
CAS Number: 137525-51-0 Frmula Molecular: C 62 H 98 N 16 O 22 Masa Molecular: 1419.56 g/mol Pureza: +99% (Verificada mediante HPLC/MS) Configuracin: Sal de acetato o forma arg bpc 157 para mayor estabilidad trmica
In addition, these medications are often used to support weight loss
By consistently lowering blood sugar levels and A1c, it helps reduce the risk of heart attack, stroke, and premature death
This can prompt glucagon to release your glycogen reserves to get you out of danger and may even reduce the amount of insulin produced
Teraoka M, Nakaso K, Kusumoto C, Katano S, Tajima N, Yamashita A, Zushi T, Ito S et al (2012) Cytoprotective effect of chlorogenic acid against -synuclein-related toxicity in catecholaminergic PC12 cells